Literature DB >> 15968264

Corticosteroids: options in the era of steroid-sparing therapy.

James Del Rosso1, Sheila Fallon Friedlander.   

Abstract

Topical corticosteroids remain the most commonly used topical treatments for inflammatory dermatoses, including psoriasis and atopic dermatitis. Topical corticosteroids are available in a variety of vehicles-creams, ointments, lotions, gels, and, more recently, foam. The vehicle used can substantially affect the individual agent's clinical action, potency, and acceptability to the patient. Moreover, some vehicles are better suited for specific body areas. Selection of the appropriate product should be determined by area of usage, physician experience, cost, and patient preference, particularly regarding vehicle. Although topical corticosteroids are associated with several side effects, including skin atrophy, telangiectases, purpura, and striae formation, appropriate usage can minimize these occurrences. Judicious use includes short-term, appropriate application as initial monotherapy or in combination strategies with other therapeutic agents that ideally possess complementing mechanisms of action. Examples include pulsing with high-potency topical corticosteroids and combination regimens with other topical agents such as topical calcineurin inhibitors, calcipotriene, or tazarotene. Appropriate education of patients and caregivers alike will facilitate the optimal use of these medications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968264     DOI: 10.1016/j.jaad.2005.04.030

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  28 in total

1.  The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin.

Authors:  James Q Del Rosso; Jacqueline Levin
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

2.  The rationale behind topical vitamin d analogs in the treatment of psoriasis: where does topical calcitriol fit in?

Authors:  Grace K Kim
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

3.  Pathways to managing atopic dermatitis: consensus from the experts.

Authors:  Mark G Lebwohl; James Q Del Rosso; William Abramovits; Brian Berman; David E Cohen; Emma Guttman; Anthony J Mancini; Lawrence A Schachner
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

4.  Suppression of cytokine gene expression and improved therapeutic efficacy of microemulsion-based tacrolimus cream for atopic dermatitis.

Authors:  Manisha S Lalan; Naresh C Laddha; Jigar Lalani; Muhammad J Imran; Rasheedunnisa Begum; Ambikanandan Misra
Journal:  Drug Deliv Transl Res       Date:  2012-04       Impact factor: 4.617

5.  Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-08

6.  Aspartame Attenuates 2, 4-Dinitrofluorobenzene-Induced Atopic Dermatitis-Like Clinical Symptoms in NC/Nga Mice.

Authors:  Gun-Dong Kim; Yong Seek Park; Hyun-Jong Ahn; Jeong-Je Cho; Cheung-Seog Park
Journal:  J Invest Dermatol       Date:  2015-06-22       Impact factor: 8.551

7.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Timothy G Berger; Alfons Krol; Amy S Paller; Kathryn Schwarzenberger; James N Bergman; Sarah L Chamlin; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Steven R Feldman; Jon M Hanifin; David J Margolis; Robert A Silverman; Eric L Simpson; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2014-05-09       Impact factor: 11.527

8.  Effect of German chamomile oil application on alleviating atopic dermatitis-like immune alterations in mice.

Authors:  Soon-Hee Lee; Yong Heo; Young-Chul Kim
Journal:  J Vet Sci       Date:  2010-03       Impact factor: 1.603

9.  Topical corticosteroid application and the structural and functional integrity of the epidermal barrier.

Authors:  James Q Del Rosso; Kimberly Cash
Journal:  J Clin Aesthet Dermatol       Date:  2013-11

10.  A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses.

Authors:  James Q Del Rosso; Leon Kircik
Journal:  J Clin Aesthet Dermatol       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.